Dec 08, 2017 23:00 pm UTC| Business
SALT LAKE CITY, Dec. 08, 2017 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced new results from two studies with EndoPredict® are being featured at the...
Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Dec 08, 2017 22:53 pm UTC| Business
INDIANAPOLIS, Dec. 08, 2017 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...
Dec 08, 2017 22:53 pm UTC| Business
NEWPORT BEACH, Calif., Dec. 08, 2017 -- The Securities Arbitration Law Firm of Klayman Toskes, P.A., www.nasd-law.com, has commenced an investigation into the sales of notes by brokerage firms and financial advisors...
Innsuites Hospitality Trust (iht) Doubles Dividend
Dec 08, 2017 22:35 pm UTC| Business
Phoenix, AZ, Dec. 08, 2017 -- InnSuites Hospitality Trust (NYSE American: IHT) The Board of Trustees of InnSuites Hospitality Trust (“IHT”) declared a dividend of $0.01 per share payable on January 31, 2018 to...
BDA and industry reps meet with top law firms in Miami
Dec 08, 2017 22:21 pm UTC| Business
HAMILTON, Bermuda, Dec. 08, 2017 -- Bermuda delegation meetings with several international law firms in Miami this week will help forge the island’s “playlist” to develop new Latin American business from the region,...
Dec 08, 2017 22:20 pm UTC| Business
NEW YORK, Dec. 08, 2017 -- The Klein Law Firm announces that a class action complaint has been filed on behalf investors who purchased 7.60% Senior Notes, Series P, due 2039, of CenturyLink, Inc. (NYSE:CTL) between...
Dec 08, 2017 22:11 pm UTC| Business
NEW YORK, Dec. 08, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased RYB Education,...
China's Economic Resurgence: Strong Growth Signals a Bright Future Ahead
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update